Berberine Improves Glucose and Lipid Metabolism in Obese Mice Through the Reduction of IRE1/GSK-3β Axis-Mediated Inflammation
BBR improves glucose and lipid metabolism in obese mice through the reduction of IRE1/GSK-3β axis-mediated inflammation, showing the great potential of BBR in reversing insulin resistance in obesity.
Authors
- Junyi Qian (ORCID: https://orcid.org/0000-0001-5482-2753)
- Jing Xia (ORCID: https://orcid.org/0000-0002-9243-9082)
- Wenbin Shang (ORCID: https://orcid.org/0000-0002-0317-5928)
- Yang Yang (ORCID: https://orcid.org/0000-0002-1163-2359)
- Hua Wang (ORCID: https://orcid.org/0000-0002-2605-5697)
- Ming Chen (ORCID: https://orcid.org/0000-0002-3470-1062)
- Jingjing Xia
- Xiaodan Jin
- Lina Ding
Institutions
- Nanjing University of Chinese Medicine (CN)
- Jiangyin People's Hospital (CN)
Publication Details
- Journal
- Endocrine Metabolic & Immune Disorders - Drug Targets
- Published
- 2025-01-10
- DOI
- https://doi.org/10.2174/0118715303319434241113161606
- Citations
- 2
- Primary Topic
- Berberine and alkaloids research
- Type
- article
- Field-Weighted Citation Impact
- 2.79
Funders
- Nanjing University